Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia (ACellDREAM2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03968198
Recruitment Status : Not yet recruiting
First Posted : May 30, 2019
Last Update Posted : January 9, 2020
Sponsor:
Collaborators:
Institut National de la Santé Et de la Recherche Médicale, France
Etablissement Français du Sang
Information provided by (Responsible Party):
University Hospital, Toulouse

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : July 2023